po.tc

Daily archive

Cannabis industry news

A growing archive of sourced cannabis industry coverage across regulation, medical markets, licensing, imports, retail, and public-company developments.

Showing 76-77 of 77

EU

Germany’s 2026 medical cannabis ramp is real, but the market still runs on imports

Official forecasts show German cannabis production rising sharply in 2026, yet regulator data indicate that Europe’s biggest medical market will remain dependent on foreign supply.

Germany’s official cannabis production estimate for 2026 has risen to 13,700 kilograms. The comparable estimate for 2025 was 2,360 kilograms. That is a near sixfold increase in one year, based on International Narcotics Control Board figures used in the global...

Read article
US

DOJ’s Schedule III Carve-Out Turns State Medical Cannabis Licenses Into Immediate Tax Assets

A final rule effective April 23 moved FDA-approved marijuana products and marijuana handled under qualifying state medical licenses into Schedule III, removing federal 280E tax drag for medical operators while adult-use businesses remain in Schedule I pending a summer DEA hearing.

On April 23, 2026, the Department of Justice and the Drug Enforcement Administration issued a final rule that immediately placed FDA-approved marijuana products, and marijuana products handled under a qualifying state-issued medical license, into Schedule III. On the same day,...

Read article